Skip to main content

Five9 Inc

For the period ended Sep 30, 2024. Filed Nov 7, 2024.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Sep 30, 2024 · Filed Nov 7, 2024

FIVN$27.75-3.9%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Condensed Consolidated Statements of Cash Flows (Unaudited)

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited, in thousands)

Nine Months Ended
September 30, 2024September 30, 2023
Cash flows from operating activities:
Net loss$(24,372)$(69,406)
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation and amortization38,26535,553
Amortization of operating lease right-of-use assets10,6319,234
Amortization of deferred contract acquisition costs52,15240,088
Accretion of discount on marketable investments(16,833)(7,684)
Provision for credit losses806795
Stock-based compensation127,872156,721
Amortization of discount and issuance costs on convertible senior notes3,9912,793
Gain on early extinguishment of debt(6,615)—
Impairment charge of an equity investment1,250—
Interest on finance lease obligations25877
Deferred taxes441438
Tax benefit of valuation allowance associated with an acquisition(4,831)—
Other(145)592
Changes in operating assets and liabilities:
Accounts receivable(15,559)(6,661)
Prepaid expenses and other current assets(9,562)(6,537)
Deferred contract acquisition costs(76,288)(68,410)
Other assets(1,452)(4,892)
Accounts payable8,6515,562
Accrued and other current liabilities5,380(1,149)
Deferred revenue1841,544
Other liabilities(871)3,636
Net cash provided by operating activities93,35392,294
Cash flows from investing activities:
Purchases of marketable investments(993,483)(544,713)
Proceeds from sales of marketable investments93,995971
Proceeds from maturities of marketable investments829,122415,117
Purchases of property and equipment(33,097)(19,941)
Capitalization of software development costs(14,211)(5,820)
Cash paid to acquire Acqueon Inc.(167,166)—
Cash paid to acquire Aceyus, Inc.99(80,588)
Net cash used in investing activities(284,741)(234,974)
Cash flows from financing activities:
Proceeds from issuance of 2029 convertible senior notes, net of issuance costs728,843—
Payments for capped call transactions associated with the 2029 convertible senior notes(93,438)—
Repurchase of a portion of 2025 convertible senior notes, net of costs(304,485)—
Repayment of outstanding 2023 convertible senior notes at maturity—(169)
Cash received from the settlement at maturity of the outstanding capped calls associated with the 2023 convertible senior notes—74,453
Cash received from partial termination of capped calls associated with the 2025 convertible senior notes539—
Proceeds from exercise of common stock options4238,315
Proceeds from sale of common stock under ESPP9,5229,444
Payment of holdback related to an acquisition—(500)
Payment of finance lease liabilities(2,006)(496)
Net cash provided by financing activities339,39891,047
Net increase (decrease) in cash, cash equivalents and restricted cash148,010(51,633)
Cash, cash equivalents and restricted cash:
Beginning of period144,842180,987
End of period$292,852$129,354
Supplemental disclosures of cash flow data:
Cash paid for interest$5,764$1,956
Cash paid for income taxes$3,337$1,124
Non-cash investing and financing activities:
Property and equipment unpaid at period-end$12,944$11,419
Capitalization of leasehold improvements and furniture and fixtures through non-cash lease incentive$37$—
Acquisition and related transaction costs accrued at period-end$591$330
Stock-based compensation included in capitalized software development costs$5,707$2,487
Reconciliation of Cash, Cash Equivalents and Restricted Cash to the Condensed Consolidated Balance Sheets - Beginning of Period:
Cash and cash equivalents$143,201$180,520
Restricted cash in other assets1,641467
Total cash, cash equivalents and restricted cash$144,842$180,987
Reconciliation of Cash, Cash Equivalents and Restricted Cash to the Condensed Consolidated Balance Sheets - End of Period:
Cash and cash equivalents$290,959$127,828
Restricted cash in other assets1,8931,526
Total cash, cash equivalents and restricted cash$292,852$129,354
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.